Current Location: HOME >> Enterprise Certification
Contact information
| Country: | China |
|---|---|
| Tel: | |
| Mobile: | 18883908398 |
| E-mail: | yingqiang.he1@portonpharma.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | Fangzheng Avenue, Shuitu, Beibei District, Chongqing, China. |
Gold product
- CAS:51773-92-3
- Purity:To be communicated
- CAS:86087-23-2
- Purity:To be communicated
-
(3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydro-furan
- CAS:915095-94-2
- Purity:To be communicated
Company Profile
-
Enterprise Basic Information
Enterprise Certification
 |
|
| Type of Enterprise: | company limited by shares |
| Legal Representative: | Ju Nianfeng |
| Registered Capital: | RMB 544.12 Million |
| Founded Date: | 2005-07-07 |
| Registered Address: | 1 Fine Chemical Zone, Chongqing Chemical Industry Park, Changshou, Chongqing, 401221, China |
| Term of Validity: | Long-term |
| Business Scope: | Licensed items: production of raw materials (operating in accordance with the approved items and term of the drug production license); Drug sales (shall obtain relevant administrative license or approval before engaging in business); Import and export of goods, import and export of technologies, and production of hazardous chemicals (For items subject to approval according to law, business activities can only be carried out after approval by relevant departments, and specific business items shall be subject to approval documents or licenses of relevant departments) General projects: technological development and technical services of innovative drugs; Research and development of chemical apis (including small and medium-sized reagents), technology transfer and technical services; Production and sales of pharmaceutical intermediates and fine chemicals (licensed business items excluding hazardous chemicals and precursor chemicals); Research and development and production of new drugs using bioengineering technology (only after obtaining relevant administrative license or approval can they be engaged in business); Biotechnology and biomedical engineering technology development, technology transfer, technical services; Chemical preparation manufacturing (only after obtaining relevant administrative permission or examination and approval) (Except for items subject to approval according to law, independently carry out business activities according to law with business license) |
| Staff number: | Above 500 People |
| Number of R & D department: | 5-10 |
| Annual turnover： | RMB Above 100 million |
| Main consumer market： | Pharmaceutical factory trading company Research InstituteL Fine chemical plant |
| Main marketing location： | India United States Brazil Egypt Turkey |
| Main product or service： | products |
Manufacturer
| Marketing : | Porton Pharma Solutions Ltd. |
| Address: | No.7, Yuntu Road, Beibei District, Chongqing, 400714, China |
| Area: | |
| Pictures of scenes: | |
|
|
|
| Marketing : | Porton Pharma Solutions Ltd（Changshou Manufacturin |
| Address: | 1 Fine Chemical Zone, Chongqing Chemical Industry Park, Changshou, Chongqing, 401221, China |
| Area: | 1000m3 |
| Equipment: | factory3 |
| Pictures of scenes: | |
|
|
| Marketing : | Porton Pharma (Jiangxi) Co., Ltd. |
| Address: | No. 618, 2nd Industrial Road, Fengxin Hi-tech Industrial Park, Yichun, Jiangxi, 330700, China |
| Area: | 500m3 |
| Equipment: | factory |
| Pictures of scenes: | |
|
|
| Marketing : | Hubei Yuyang Pharmaceutical Co., Ltd |
| Address: | No.1 Fazhan Road, Changjiangbu District, Yingcheng, Hubei 432405, China |
| Area: | 600m3 |
| Equipment: | factory |
| Pictures of scenes: | |
|
|
| Marketing : | China Gateway Pharmaceutical Development Co., Ltd. |
| Address: | Building 3.No.99,Lianhe South Road,Fengxian District, Shanghai 201417, China |
| Area: | 100m3 |
| Equipment: | factory |
| Pictures of scenes: | |
|
|
| Brief description : | Our Quality system is anchored by a deep understanding of current Good Manufacturing Practices (cGMPs) and ICH Q7 guidelines. We design quality into every manufacturing process we develop and scale for you, and execute every aspect of our work to the highest standards. Whether in support of clinical development or process validation / launch planning of new chemical entities (NCEs) or life-cycle management of mature products – Porton’s multi-functional teams are focused on ensuring your product’ |
| Quality inspection equipment: | - |
|
|
| Certificate of accreditation: | WHO 2020 Page2 |
| Brief description : | Porton has two major manufacturing facilities in China: Changshou [Chongqing Metro Region] and Dongbang [Jiangxi Province]. Using a formal technology transfer system, site teams at these facilities have a highly successful track record of collaborating with the our three Process R&D centers to seamlessly provide integrated small molecule solutions, ranging from GLP tox lots, Phase I-IIII clinical supplies to full-scale commercial production in gram to MT quantities. |
| Pictures of scenes: | |
|
|
|
| Staff composition for example: | |
| Professional skills: | |
| Pictures of scenes: | |